Industry to Biden: Count Us In On Cancer Moonshot
Executive Summary
AdvaMed says the medtech industry needs to at the table to advise the government on investments that could lead to future cancer diagnostics and treatments.
You may also be interested in...
FDA Draft Guidance Takes Aim At Racial, Ethnic Disparities In Clinical Trials
The US agency has outlined steps industry can take to ensure clinical trials include a broader representation of underrepresented racial and ethnic groups.
Biden Announces New Direction For COVID-19 Policy In Annual Address
Proposals in the speech that could affect the device industry include “one-stop shops” for COVID-19 testing and treatment, additional funding to stockpile tests and masks, and a new government center devoted to health care research.
Device-Makers Can Help With Cancer ‘Moonshot,' AdvaMed Tells Biden
Medical technology plays an important role in cancer treatment and cures via diagnostics and precision medicine, advanced imaging, radiation therapy and surgical oncology, AdvaMed told Vice President Joe Biden in a March 31 letter asking for a meeting with the National Cancer “Moonshot” Task Force.